Still in ‘stealth mode’, OsteoMime is being developed using Locate Bio’s core competency of Programmed Drug Release to address a significant unmet need in revision spinal surgeries.
![](https://locatebio.com/wp-content/uploads/2023/11/5S1A1122-1024x683.jpg)
![](https://locatebio.com/wp-content/uploads/2023/11/5S1A0985-1620x1080.jpg)
![](https://locatebio.com/wp-content/uploads/2023/11/5S1A0975-1620x1080.jpg)
![](https://locatebio.com/wp-content/uploads/2023/11/5S1A1440-1620x1080.jpg)
*For investigational use only, not approved for sale
Still in ‘stealth mode’, OsteoMime is being developed using Locate Bio’s core competency of Programmed Drug Release to address a significant unmet need in revision spinal surgeries.
*For investigational use only, not approved for sale